Skip to main content

Table 3 Therapeutic approach for thirty-one cSLE patients at the beginning of the study

From: Higher interferon score and normal complement levels may identify a distinct clinical subset in children with systemic lupus erythematosus

Total, n = 31

n (%)

Cyclophosphamide

17 (55.0)

Azathioprine

13 (42.0)

Mycophenolate mofetil

13 (42.0)

Rituximab

3 (9.6)

Immunoglobulins

5 (16.0)

Tacrolimus

3 (9.6)

Methotrexate

1 (3.2)

Hydroxychloroquine

31 (100.0)

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us